Dendreon Turning the Page on Losses Via Chapter 11 - Genetic Enginee...

11/10/14

Dendreon Turning the Page on Losses Via Chapter 11
Genetic Engineering & Biotechnology News
Prostate cancer drug developer Dendreon said today it filed for Chapter 11 bankruptcy protection as part of a financial restructuring agreed upon with senior lenders that may result in a recapitalization or sale of the company or its assets, led by its ...